Investigation of the Efficacy and Safety of CHI-921 in Insomnia.
Status:
Terminated
Trial end date:
2020-06-17
Target enrollment:
Participant gender:
Summary
Insomnia is a disorder where people are having trouble sleeping and can include difficulty
falling asleep, staying asleep and waking up too early, as well as having unrefreshing sleep.
CHI-921 is a cannabis extract in sunflower oil produced as a treatment for insomnia. This
trial is designed to evaluate the efficacy and safety of CHI-921 on people with insomnia.
Phase:
Phase 2
Details
Lead Sponsor:
Canopy Growth Corporation Canopy Health Innovations